BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12630912)

  • 1. The soluble ectodomain of RetC634Y inhibits both the wild-type and the constitutively active Ret.
    Cerchia L; Libri D; Carlomagno MS; de Franciscis V
    Biochem J; 2003 Jun; 372(Pt 3):897-903. PubMed ID: 12630912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations.
    Ohiwa M; Murakami H; Iwashita T; Asai N; Iwata Y; Imai T; Funahashi H; Takagi H; Takahashi M
    Biochem Biophys Res Commun; 1997 Aug; 237(3):747-51. PubMed ID: 9299438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation.
    Bongarzone I; Vigano E; Alberti L; Borrello MG; Pasini B; Greco A; Mondellini P; Smith DP; Ponder BA; Romeo G; Pierotti MA
    Oncogene; 1998 May; 16(18):2295-301. PubMed ID: 9620546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor.
    Plaza Menacho I; Koster R; van der Sloot AM; Quax WJ; Osinga J; van der Sluis T; Hollema H; Burzynski GM; Gimm O; Buys CH; Eggen BJ; Hofstra RM
    Cancer Res; 2005 Mar; 65(5):1729-37. PubMed ID: 15753368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.
    Mograbi B; Bocciardi R; Bourget I; Juhel T; Farahi-Far D; Romeo G; Ceccherini I; Rossi B
    Mol Cell Biol; 2001 Oct; 21(20):6719-30. PubMed ID: 11564857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival.
    De Vita G; Melillo RM; Carlomagno F; Visconti R; Castellone MD; Bellacosa A; Billaud M; Fusco A; Tsichlis PN; Santoro M
    Cancer Res; 2000 Jul; 60(14):3727-31. PubMed ID: 10919641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines.
    Chappuis-Flament S; Pasini A; De Vita G; Ségouffin-Cariou C; Fusco A; Attié T; Lenoir GM; Santoro M; Billaud M
    Oncogene; 1998 Dec; 17(22):2851-61. PubMed ID: 9879991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations.
    Takahashi M; Asai N; Iwashita T; Murakami H; Ito S
    Recent Results Cancer Res; 1998; 154():229-36. PubMed ID: 10027003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for GFR alpha 4 function and a potential modifying role in multiple endocrine neoplasia 2.
    Vanhorne JB; Andrew SD; Harrison KJ; Taylor SA; Thomas B; McDonald TJ; Ainsworth PJ; Mulligan LM
    Oncogene; 2005 Feb; 24(6):1091-7. PubMed ID: 15592530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of activation and superactivation of Ret tyrosine kinases by ultraviolet light irradiation.
    Kato M; Iwashita T; Akhand AA; Liu W; Takeda K; Takeuchi K; Yoshihara M; Hossain K; Wu J; Du J; Oh C; Kawamoto Y; Suzuki H; Takahashi M; Nakashima I
    Antioxid Redox Signal; 2000; 2(4):841-9. PubMed ID: 11213488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation.
    Hayashi Y; Iwashita T; Murakamai H; Kato Y; Kawai K; Kurokawa K; Tohnai I; Ueda M; Takahashi M
    Biochem Biophys Res Commun; 2001 Mar; 281(3):682-9. PubMed ID: 11237712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease.
    Arighi E; Popsueva A; Degl'Innocenti D; Borrello MG; Carniti C; Perälä NM; Pierotti MA; Sariola H
    Mol Endocrinol; 2004 Apr; 18(4):1004-17. PubMed ID: 14715928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of RET, GFR alpha 1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A.
    Gil L; Azañedo M; Pollán M; Cristobal E; Arribas B; García-Albert L; García-Sáiz A; Maestro ML; Torres A; Menárguez J; Rojas JM
    Int J Cancer; 2002 May; 99(2):299-304. PubMed ID: 11979448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of GFRalpha1 domain 3 reveals new insights into GDNF binding and RET activation.
    Leppänen VM; Bespalov MM; Runeberg-Roos P; Puurand U; Merits A; Saarma M; Goldman A
    EMBO J; 2004 Apr; 23(7):1452-62. PubMed ID: 15044950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a surface for binding to the GDNF-GFR alpha 1 complex in the first cadherin-like domain of RET.
    Kjaer S; Ibáñez CF
    J Biol Chem; 2003 Nov; 278(48):47898-904. PubMed ID: 14514671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct interactions among Ret, GDNF and GFRalpha1 molecules reveal new insights into the assembly of a functional three-protein complex.
    Amoresano A; Incoronato M; Monti G; Pucci P; de Franciscis V; Cerchia L
    Cell Signal; 2005 Jun; 17(6):717-27. PubMed ID: 15722196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structure-function analysis of glial cell-line-derived neurotrophic factor receptor alpha1.
    Wang LM; Chen ZY; Zhang Q; Zhu W; Ding DF; Lu CL; He C
    Protein Pept Lett; 2003 Feb; 10(1):61-72. PubMed ID: 12625827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraviolet light induces redox reaction-mediated dimerization and superactivation of oncogenic Ret tyrosine kinases.
    Kato M; Iwashita T; Takeda K; Akhand AA; Liu W; Yoshihara M; Asai N; Suzuki H; Takahashi M; Nakashima I
    Mol Biol Cell; 2000 Jan; 11(1):93-101. PubMed ID: 10637293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cells of the human optic nerve head express glial cell line-derived neurotrophic factor (GDNF) and the GDNF receptor complex.
    Wordinger RJ; Lambert W; Agarwal R; Liu X; Clark AF
    Mol Vis; 2003 Jun; 9():249-56. PubMed ID: 12813408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutations.
    Kjaer S; Kurokawa K; Perrinjaquet M; Abrescia C; Ibáñez CF
    Oncogene; 2006 Nov; 25(53):7086-95. PubMed ID: 16732321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.